Table 1.
Characteristics of patients.
| N° | Diagnosis | Mutation | Disease activity | CRP (mg/dL) | SAA (mg/L) | Treatment |
|---|---|---|---|---|---|---|
| 1 | FMF | M694V/M694V | Mild | 1,82 | 145 | Colchicine |
| 2 | FMF | M694V/V726A | Almost absent | 1,16 | 26 | Colchicine |
| 3 | FMF | M694V/V726A | None | <0,46 | 15,3 | None |
| 4 | FMF | M680I/V726A | None | <0,46 | 14,2 | Colchicine |
| 5 | FMF | M694V/M694V | None | <0,46 | 4,2 | Colchicine |
| 6 | TRAPS | C55Y | None | <0,46 | 2,07 | Canakinumab |
| 7 | TRAPS | C88Y | None | <0,46 | 1,8 | Canakinumab |
| 8 | TRAPS | C52Y | None | <0,46 | 5,39 | Canakinumab |
| 9 | TRAPS | T50M | None | <0,46 | 9,94 | Canakinumab |
| 10 | TRAPS | C55Y | None | <0,46 | 3,86 | Canakinumab |
| 11 | MKD | L265R/V377I | None | <0,46 | 4,1 | Canakinumab |
| 12 | MKD | C605insG/V377I | Mild | 1,21 | 135 | Canakinumab |
| 13 | MKD | C785_790delC/V377I | None | <0,46 | 7,2 | Canakinumab |
| 14 | MKD | V310M/V377I | Moderate | 3,08 | 130 | None |
| 15 | MKD | V377I/V377I | None | <0,46 | 16,8 | None |
FMF, familial Mediterranean fever; TRAPS, TNF receptor-associated periodic syndrome; MKD, mevalonate kinase deficiency; CPR, C-reactive protein; SAA, serum amyloid A.